Search

Your search keyword '"Hemingway, Cheryl"' showing total 459 results

Search Constraints

Start Over You searched for: Author "Hemingway, Cheryl" Remove constraint Author: "Hemingway, Cheryl"
459 results on '"Hemingway, Cheryl"'

Search Results

1. Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes

2. A study of referral bias in NMOSD and MOGAD cohorts

3. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

5. Investigating Radiological Lag and the Temporal Evolution of MRI Lesions Within the Same Attack in MOGAD (S32.008)

6. Repurposing Clinical MRI Archives for Multiple Sclerosis Research with a Flexible, Single-Modality Approach: New Insights from Old Scans

7. A study of referral bias in NMOSD and MOGAD cohorts

9. A systematic review of the epidemiology of pediatric autoimmune encephalitis: disease burden and clinical decision-making.

10. E.U. paediatric MOG consortium consensus: Part 3 – Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

11. E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

12. E.U. paediatric MOG consortium consensus: Part 4 – Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

13. E.U. paediatric MOG consortium consensus: Part 1 – Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

14. E.U. paediatric MOG consortium consensus: Part 2 – Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

15. International MOGAD criteria

17. Longitudinal analysis of gene expression profiles using functional mixed-effects models

22. Evolution of brain MRI lesions in paediatric myelinoligodendrocyte glycoprotein antibody- associated disease (MOGAD) and its relevance to disease course.

23. Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course

25. Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?

26. Real-World Effectiveness of Ocrelizumab in a Multi-Centre Pediatric-Onset Multiple Sclerosis (POMS) Cohort in the United Kingdom (S31.007)

27. Dynamic MRI Lesion Evolution in Pediatric Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) (S27.006)

29. Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course

30. Neuroimaging in encephalitis: analysis of imaging findings and interobserver agreement

32. Investigation of the molecular mechanisms of the inhibition of hepatic fatty acid and cholesterol biosynthesis by hypolipidaemic agents

33. Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course

36. Contributors

38. Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom

39. Clinical features, investigations, and outcomes of pediatric limbic encephalitis:A multicenter study

41. Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom

42. Clinical features, investigations, and outcomes of pediatric limbic encephalitis: A multicenter study

45. Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom

46. OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis

48. Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders

Catalog

Books, media, physical & digital resources